Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker

Roberta Lizio, Claudio Del Percio, Nicola Marzano, Andrea Soricelli, Görsev G. Yener, Erol Basąr, Ciro Mundi, Salvatore De Rosa, Antonio Ivano Triggiani, Raffaele Ferri, Dario Arnaldi, Flavio Mariano Nobili, Susanna Cordone, Susanna Lopez, Filippo Carducci, Giulia Santi, Loreto Gesualdo, Paolo M. Rossini, Enrica Cavedo, Margherita MauriGiovanni B. Frisoni, Claudio Babiloni

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Here we presented a single electroencephalographic (EEG) marker for a neurophysiological assessment of Alzheimer's disease (AD) patients already diagnosed by current guidelines. The ability of the EEG marker to classify 127 AD individuals and 121 matched cognitively intact normal elderly (Nold) individuals was tested. Furthermore, its relationship to AD patients' cognitive status and structural brain integrity was examined. Low-resolution brain electromagnetic tomography (LORETA) freeware estimated cortical sources of resting state eyes-closed EEG rhythms. The EEG marker was defined as the ratio between the activity of parieto-occipital cortical sources of delta (2-4 Hz) and low-frequency alpha (8-10.5 Hz) rhythms. Results showed 77.2% of sensitivity in the recognition of the AD individuals; 65% of specificity in the recognition of the Nold individuals; and 0.75 of area under the receiver-operating characteristic curve. Compared to the AD subgroup with the EEG maker within one standard deviation of the Nold mean (EEG-), the AD subgroup with EEG+ showed lower global cognitive status, as revealed by Mini-Mental State Evaluation score, and more abnormal values of white-matter and cerebrospinal fluid normalized volumes, as revealed by structural magnetic resonance imaging. We posit that cognitive and functional status being equal, AD patients with EEG+ should receive special clinical attention due to a neurophysiological "frailty". EEG+ label can be also used in clinical trials (i) to form homogeneous groups of AD patients diagnosed by current guidelines and (ii) as end-point to evaluate intervention effects.

Original languageEnglish
Pages (from-to)159-177
Number of pages19
JournalJournal of Alzheimer's Disease
Volume49
Issue number1
DOIs
Publication statusPublished - 2015

Fingerprint

Alzheimer Disease
Guidelines
Aptitude
Electromagnetic Phenomena
Brain
ROC Curve
Cerebrospinal Fluid
Tomography
Magnetic Resonance Imaging
Clinical Trials

Keywords

  • Alpha rhythms
  • Alzheimer's disease
  • delta rhythms
  • electroencephalography
  • low resolution brain electromagnetic tomography (LORETA)
  • neurophysiological assessment

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker. / Lizio, Roberta; Del Percio, Claudio; Marzano, Nicola; Soricelli, Andrea; Yener, Görsev G.; Basąr, Erol; Mundi, Ciro; De Rosa, Salvatore; Triggiani, Antonio Ivano; Ferri, Raffaele; Arnaldi, Dario; Nobili, Flavio Mariano; Cordone, Susanna; Lopez, Susanna; Carducci, Filippo; Santi, Giulia; Gesualdo, Loreto; Rossini, Paolo M.; Cavedo, Enrica; Mauri, Margherita; Frisoni, Giovanni B.; Babiloni, Claudio.

In: Journal of Alzheimer's Disease, Vol. 49, No. 1, 2015, p. 159-177.

Research output: Contribution to journalArticle

Lizio, R, Del Percio, C, Marzano, N, Soricelli, A, Yener, GG, Basąr, E, Mundi, C, De Rosa, S, Triggiani, AI, Ferri, R, Arnaldi, D, Nobili, FM, Cordone, S, Lopez, S, Carducci, F, Santi, G, Gesualdo, L, Rossini, PM, Cavedo, E, Mauri, M, Frisoni, GB & Babiloni, C 2015, 'Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker', Journal of Alzheimer's Disease, vol. 49, no. 1, pp. 159-177. https://doi.org/10.3233/JAD-143042
Lizio, Roberta ; Del Percio, Claudio ; Marzano, Nicola ; Soricelli, Andrea ; Yener, Görsev G. ; Basąr, Erol ; Mundi, Ciro ; De Rosa, Salvatore ; Triggiani, Antonio Ivano ; Ferri, Raffaele ; Arnaldi, Dario ; Nobili, Flavio Mariano ; Cordone, Susanna ; Lopez, Susanna ; Carducci, Filippo ; Santi, Giulia ; Gesualdo, Loreto ; Rossini, Paolo M. ; Cavedo, Enrica ; Mauri, Margherita ; Frisoni, Giovanni B. ; Babiloni, Claudio. / Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker. In: Journal of Alzheimer's Disease. 2015 ; Vol. 49, No. 1. pp. 159-177.
@article{328e68a615eb43718d74eeca98dae3b6,
title = "Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker",
abstract = "Here we presented a single electroencephalographic (EEG) marker for a neurophysiological assessment of Alzheimer's disease (AD) patients already diagnosed by current guidelines. The ability of the EEG marker to classify 127 AD individuals and 121 matched cognitively intact normal elderly (Nold) individuals was tested. Furthermore, its relationship to AD patients' cognitive status and structural brain integrity was examined. Low-resolution brain electromagnetic tomography (LORETA) freeware estimated cortical sources of resting state eyes-closed EEG rhythms. The EEG marker was defined as the ratio between the activity of parieto-occipital cortical sources of delta (2-4 Hz) and low-frequency alpha (8-10.5 Hz) rhythms. Results showed 77.2{\%} of sensitivity in the recognition of the AD individuals; 65{\%} of specificity in the recognition of the Nold individuals; and 0.75 of area under the receiver-operating characteristic curve. Compared to the AD subgroup with the EEG maker within one standard deviation of the Nold mean (EEG-), the AD subgroup with EEG+ showed lower global cognitive status, as revealed by Mini-Mental State Evaluation score, and more abnormal values of white-matter and cerebrospinal fluid normalized volumes, as revealed by structural magnetic resonance imaging. We posit that cognitive and functional status being equal, AD patients with EEG+ should receive special clinical attention due to a neurophysiological {"}frailty{"}. EEG+ label can be also used in clinical trials (i) to form homogeneous groups of AD patients diagnosed by current guidelines and (ii) as end-point to evaluate intervention effects.",
keywords = "Alpha rhythms, Alzheimer's disease, delta rhythms, electroencephalography, low resolution brain electromagnetic tomography (LORETA), neurophysiological assessment",
author = "Roberta Lizio and {Del Percio}, Claudio and Nicola Marzano and Andrea Soricelli and Yener, {G{\"o}rsev G.} and Erol Basąr and Ciro Mundi and {De Rosa}, Salvatore and Triggiani, {Antonio Ivano} and Raffaele Ferri and Dario Arnaldi and Nobili, {Flavio Mariano} and Susanna Cordone and Susanna Lopez and Filippo Carducci and Giulia Santi and Loreto Gesualdo and Rossini, {Paolo M.} and Enrica Cavedo and Margherita Mauri and Frisoni, {Giovanni B.} and Claudio Babiloni",
year = "2015",
doi = "10.3233/JAD-143042",
language = "English",
volume = "49",
pages = "159--177",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Neurophysiological Assessment of Alzheimer's Disease Individuals by a Single Electroencephalographic Marker

AU - Lizio, Roberta

AU - Del Percio, Claudio

AU - Marzano, Nicola

AU - Soricelli, Andrea

AU - Yener, Görsev G.

AU - Basąr, Erol

AU - Mundi, Ciro

AU - De Rosa, Salvatore

AU - Triggiani, Antonio Ivano

AU - Ferri, Raffaele

AU - Arnaldi, Dario

AU - Nobili, Flavio Mariano

AU - Cordone, Susanna

AU - Lopez, Susanna

AU - Carducci, Filippo

AU - Santi, Giulia

AU - Gesualdo, Loreto

AU - Rossini, Paolo M.

AU - Cavedo, Enrica

AU - Mauri, Margherita

AU - Frisoni, Giovanni B.

AU - Babiloni, Claudio

PY - 2015

Y1 - 2015

N2 - Here we presented a single electroencephalographic (EEG) marker for a neurophysiological assessment of Alzheimer's disease (AD) patients already diagnosed by current guidelines. The ability of the EEG marker to classify 127 AD individuals and 121 matched cognitively intact normal elderly (Nold) individuals was tested. Furthermore, its relationship to AD patients' cognitive status and structural brain integrity was examined. Low-resolution brain electromagnetic tomography (LORETA) freeware estimated cortical sources of resting state eyes-closed EEG rhythms. The EEG marker was defined as the ratio between the activity of parieto-occipital cortical sources of delta (2-4 Hz) and low-frequency alpha (8-10.5 Hz) rhythms. Results showed 77.2% of sensitivity in the recognition of the AD individuals; 65% of specificity in the recognition of the Nold individuals; and 0.75 of area under the receiver-operating characteristic curve. Compared to the AD subgroup with the EEG maker within one standard deviation of the Nold mean (EEG-), the AD subgroup with EEG+ showed lower global cognitive status, as revealed by Mini-Mental State Evaluation score, and more abnormal values of white-matter and cerebrospinal fluid normalized volumes, as revealed by structural magnetic resonance imaging. We posit that cognitive and functional status being equal, AD patients with EEG+ should receive special clinical attention due to a neurophysiological "frailty". EEG+ label can be also used in clinical trials (i) to form homogeneous groups of AD patients diagnosed by current guidelines and (ii) as end-point to evaluate intervention effects.

AB - Here we presented a single electroencephalographic (EEG) marker for a neurophysiological assessment of Alzheimer's disease (AD) patients already diagnosed by current guidelines. The ability of the EEG marker to classify 127 AD individuals and 121 matched cognitively intact normal elderly (Nold) individuals was tested. Furthermore, its relationship to AD patients' cognitive status and structural brain integrity was examined. Low-resolution brain electromagnetic tomography (LORETA) freeware estimated cortical sources of resting state eyes-closed EEG rhythms. The EEG marker was defined as the ratio between the activity of parieto-occipital cortical sources of delta (2-4 Hz) and low-frequency alpha (8-10.5 Hz) rhythms. Results showed 77.2% of sensitivity in the recognition of the AD individuals; 65% of specificity in the recognition of the Nold individuals; and 0.75 of area under the receiver-operating characteristic curve. Compared to the AD subgroup with the EEG maker within one standard deviation of the Nold mean (EEG-), the AD subgroup with EEG+ showed lower global cognitive status, as revealed by Mini-Mental State Evaluation score, and more abnormal values of white-matter and cerebrospinal fluid normalized volumes, as revealed by structural magnetic resonance imaging. We posit that cognitive and functional status being equal, AD patients with EEG+ should receive special clinical attention due to a neurophysiological "frailty". EEG+ label can be also used in clinical trials (i) to form homogeneous groups of AD patients diagnosed by current guidelines and (ii) as end-point to evaluate intervention effects.

KW - Alpha rhythms

KW - Alzheimer's disease

KW - delta rhythms

KW - electroencephalography

KW - low resolution brain electromagnetic tomography (LORETA)

KW - neurophysiological assessment

UR - http://www.scopus.com/inward/record.url?scp=84948690979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948690979&partnerID=8YFLogxK

U2 - 10.3233/JAD-143042

DO - 10.3233/JAD-143042

M3 - Article

C2 - 26444753

AN - SCOPUS:84948690979

VL - 49

SP - 159

EP - 177

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -